News
GlaxoSmithKline Pharmaceuticals to launch oncology assets Jemperli and Zejula in India, addressing critical unmet needs in ...
Both Bowman and Waller were appointed by Trump, who has repeatedly lambasted Fed Chair Jerome Powell for not cutting rates. The jobs shock added to the already downbeat market mood after Trump ...
The Clinical Advisor spoke with Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC, about how the changes to ACIP will affect vaccination recommendations moving forward. Dr Stevenson is a faculty member of ...
Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for ...
Patients with bronchiectasis from different European countries have strikingly different variations in microbiome composition and resistome.
France's CAC 40 fell 1.8%, and Germany's DAX dropped 1.7%, underlining the significant impact the new measures are having across Europe's largest economies.
Merz Aesthetics has revamped its sales and marketing leadership, promoting an employee and hiring a vice president from GSK ...
Fierce Pharma Asia—GSK's massive Hengrui deal; Takeda's revenue drop; Celltrion's major US plant buy
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...
GLAXOSMITHKLINE PHARMACEUTICALS LTD - Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and ...
GlaxoSmithKline Pharmaceuticals on Friday said its consolidated net profit increased 12 per cent year-on-year to Rs 279 crore ...
GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...
GlaxoSmithKline Pharmaceuticals Q1 net profit rises 12% to Rs 279 crore, despite slight dip in total income. Company highlights upcoming oncology drug launches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results